AGP Picks
View all

Vatican Health Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vatican Health Times.

Press releases published on October 30, 2026

Regeneron Reports Third Quarter 2026 Financial and Operating Results
Glass-Ceramics Market to Reach $2.7 Billion by 2031 as Semiconductor, Aerospace and Medical Applications Expand
Kestra Medical Technologies to Participate in Upcoming Investor Conferences
BrightSpring Health Services, Inc. Reports Third Quarter 2026 Financial Results and Increases Full Year 2026 Guidance
Repligen Announces $1 Billion Private Convertible Senior Notes Transaction
Asia-Pacific is rapidly gaining importance as a major pillar in global life science innovation
Tangram gibt bekannt, dass der erste Teilnehmer im Rahmen der Phase-I-Studie mit TGM-148, einem neuartigen RNAi-Prüfpräparat zur Behandlung von Blutungsstörungen, die erste Dosis erhalten hat
Tangram annonce l’administration du TGM-148 au premier participant de l’essai de phase 1 évaluant le TGM-148, un nouveau médicament expérimental à ARNi contre les troubles hémorragiques
Evaxion receives International Prix Galien Award for AI-Immunology™ as best digital health solution
Fangzhou Honored with Digital Intelligence Leadership Award at Tencent Summit, Expands Healthcare AI Partnership with Tencent Health
Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter 2026
Nicox Reports First Half 2026 Financial Results
Nicox publie les résultats financiers du premier semestre 2026
Press Release: Q3 2026: double-digit growth in sales and business EPS FY 2026: guidance upgraded
Communiqué de presse : T3 2026 : croissance à deux chiffres du chiffre d’affaires et du BNPA ; révision à la hausse des perspectives 2026
Leads Biolabs Doses First Patient with Systemic Lupus Erythematosus in Phase I Part B Trial of LBL-047, a First-in-Class BDCA2/TACI Bifunctional Fusion Protein
2026 InLight Foundation Stanford Frontier Dialogue: From Nobel Optogenetics to Mind-Light Contemplation, Cross-Disciplinary Experts Explore New Frontiers in Consciousness Regulation
Aspen Neuroscience Announces Pricing of Initial Public Offering
InnoCare Announces First Subject Dosed in Clinical Trial of TL1A/IL-23p19 Bispecific Antibody ICP-B161 in China

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Vatican Health Times

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.